← FDA Drug Approvals (Drugs@FDA)
SCANDONEST L
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: DEPROCO · Approved 1984-10-10
Drug application
- FDA Application #
ANDA088388- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SCANDONEST L
- Generic name
- Levonordefrin
- Active ingredients
- LEVONORDEFRIN; MEPIVACAINE HYDROCHLORIDE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Discontinued
- Sponsor
- DEPROCO
- First approval
- 1984-10-10
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown